HomeSGX-LISTED COMPANIESMetech International Posts Zero Q3FY2026 Revenue Amid Restructuring & Diamond Exit

Metech International Posts Zero Q3FY2026 Revenue Amid Restructuring & Diamond Exit

Published on

spot_img

At a glance

Who

Metech International Limited and Chief Executive Officer Pang Wei Hao

What

Released unaudited Q3FY2026 and 9MFY2026 financial results showing S$3.21 million revenue, positive equity turnaround, capital raises, and lab-grown diamond subsidiary exit

When

Third quarter and nine months ended 30 September 2026, including transactions on June 2026, 30 July 2026, and August 2026

Where

Singapore Exchange (SGX) Catalist board, with commercial operations across Singapore, the People's Republic of China, Taiwan, and Malaysia

Why

The group sought to shed loss-making assets, eliminate negative equity, and strengthen working capital. Management aims to build sustainable, revenue-generating operations

How

Metech raised S$2.86 million via share placement, capitalised S$1.50 million debt, secured a S$3.0 million loan facility, and sold Asian Eco Technology

Q3FY2026 and 9MFY2026 Show A Period of Strategic Restructuring

Metech International Limited has released its unaudited financial results for the third quarter and nine months ended 30 September 2026. For investors watching the Singapore-listed company, the latest numbers tell a story of active restructuring. While the company recorded zero revenue in the third quarter due to operational transitions in its health supplements division, it successfully strengthened its balance sheet, raised fresh capital, and exited its loss-making lab-grown diamond subsidiary.

Here is a breakdown of the key financial figures and business updates every investor needs to know.

Nine-Month Revenue Rises Despite a Quiet Third Quarter

During the third quarter (Q3FY2026), Metech International generated no revenue, matching the same period in the previous year. Management noted that this pause was due to ongoing repackaging of its health supplement products and discussions with suppliers about launching new items.

Looking at the broader nine-month period (9MFY2026), the picture is more active. Total revenue reached S$3.21 million, up 4.87% from S$3.06 million in 9MFY2025. All of this revenue came from the wholesale distribution of health supplements in the People’s Republic of China. By negotiating lower purchase prices with suppliers, the group reduced its cost of sales and boosted its nine-month gross profit by 78.99%, rising from S$338,000 to S$605,000. Gross profit margins improved from 11.04% to 18.85%.

Financial Metric (S$’000)9MFY20259MFY2026Change
Revenue3,0613,210+4.87%
Gross Profit338605+78.99%
Administrative Expenses(993)(1,832)+84.49%
Total Loss After Tax(694)(705)+1.59%
Cash and Bank Balances (Period End)44956+2,072.73%

(Note: Cash and bank balances reflect closing figures as at 30 September 2025 and 30 September 2026.)

One-Off Disposal Loss Weighs on the Bottom Line

On the bottom line, Metech International reported a total loss of S$1.06 million for Q3FY2026, compared to a loss of S$295,000 in Q3FY2025. Over the nine-month period, the total loss stood at S$705,000, remaining nearly flat compared to the S$694,000 loss recorded a year earlier.

The spike in third-quarter losses was largely driven by a jump in administrative expenses, which rose 327.92% to S$1.21 million. However, investors should note that this included a one-off, non-cash loss of S$844,000 from completing the disposal of Asian Eco Technology Pte. Ltd. (AET), its 80%-owned lab-grown diamond subsidiary. Selling AET to Wuhan Xilu Trading Co., Ltd. for S$1.00 allowed Metech to shed the subsidiary’s liabilities and exit the lab-grown diamond manufacturing segment.

Elsewhere on the income statement, other income rose significantly to S$522,000 for the nine-month period, up from S$14,000 in 9MFY2025, largely thanks to new building management income from its premises at 54 Pandan Road.

Balance Sheet and Cash Flow Improvements

For shareholders concerned about financial stability, Metech’s balance sheet showed notable progress. As at 30 September 2026, the group reversed its negative equity position, moving from a net liability of S$1.40 million at the end of 2025 to positive total equity of S$3.27 million. Working capital also swung from a negative S$1.44 million to a positive S$3.14 million.

This turnaround was supported by key capital-raising activities:

  • Share Placement: On 30 July 2026, the company raised net proceeds of approximately S$2.86 million by placing 72 million new ordinary shares. Roughly S$1.04 million of these funds went toward repaying loans, leaving S$904,000 in unutilised proceeds for general working capital.
  • Debt Capitalisation: Earlier in June 2026, the company completed a debt capitalisation exercise worth S$1.50 million.
  • Credit Facility: In August 2026, Metech secured a S$3.0 million interest-free loan facility from Mr. Cao Shixuan, which remained entirely undrawn as at 30 September 2026.

While operating activities still consumed S$2.00 million in cash over the nine months, this was an improvement from the S$3.23 million cash burn seen in 9MFY2025. Combined with the share placement proceeds, Metech ended the quarter with S$956,000 in cash and bank balances, up from S$198,000 at the start of the year. No dividends were declared as the group prioritizes restructuring and lacks accumulated profits.

Looking Ahead to Commercialisation and Expansion

While Metech’s auditors previously highlighted a material uncertainty regarding its ability to continue as a going concern, management remains confident that its cash projections, undrawn loan facility, and operational plans will sustain the business over the next 12 months.

Investors will be watching two main growth drivers in the coming quarters. First, in the health supplements business, Metech is applying for direct sales and health supplement licenses in China while working with suppliers to expand factory capacity. Second, the company is advancing its food waste and renewable resource division. Biomass carbon reduction machines have completed testing and are slated for initial commercial trials in Singapore in late 2026. Alongside international partnerships in Taiwan, Malaysia, and China, these initiatives represent Metech’s push to build sustainable, revenue-generating operations moving forward.

Related stories: TSH Resources Q3 FY2026 Results Show Resilient Core Growth Amid One-Off Headwinds

Sources & citations

  1. Metech International Limited Q3FY2026 Results
  2. Metech International Limited Q3FY2026 News
  3. Metech International Limited Financial Data & Share Price

Latest articles

TSH Resources Q3 FY2026 Results Show Resilient Core Growth Amid One-Off Headwinds

Operational Rebound Offset by Indonesian Penalty TSH Resources Berhad has released its unaudited financial results...

Wilton Resources 1QFY2026 Shows Flat Net Losses Amid Maintenance Focus & Balance Sheet Restructuring

Maintenance Focus and Funding Plans Wilton Resources Corporation Limited has released its unaudited financial results...

Fraser and Neave Delivers Operating Profit Growth In FY2026 Despite Revenue Pressures

Fraser and Neave Protects Margins and Boosts Operating Profit Amid Sales Headwinds Fraser and Neave...

Salt Investments Reports Strong Revenue Surge & Return To Profitability In 1H FY2027

Salt Investments 1H FY2027 Turnaround Driven by Marine Fuel Expansion Salt Investments Limited has released...

More like this

TSH Resources Q3 FY2026 Results Show Resilient Core Growth Amid One-Off Headwinds

Operational Rebound Offset by Indonesian Penalty TSH Resources Berhad has released its unaudited financial results...

Wilton Resources 1QFY2026 Shows Flat Net Losses Amid Maintenance Focus & Balance Sheet Restructuring

Maintenance Focus and Funding Plans Wilton Resources Corporation Limited has released its unaudited financial results...

Fraser and Neave Delivers Operating Profit Growth In FY2026 Despite Revenue Pressures

Fraser and Neave Protects Margins and Boosts Operating Profit Amid Sales Headwinds Fraser and Neave...